Very Brief Blog: Genomic Health Announces Date of Service Investigation

In its May 9, 2018, 10-Q filing with SEC, Genomic Health notes it is cooperating with an investigation into Medicare "date of service rule" compliance.

• 10-Q here.
• Search for: date of service; several hits in the 64 page PDF document.
• GHDX is up 6% in the week since mentioning the investigation.
• The May 9 document was subsequent to its May 2 investor call.
• Brief Genomeweb report here.  I believe it's open access.

In recent news, from March, there was also a compliance investigation of Myriad Genetics billing (Bloomberg here; also here).   As often occurs, there is a parallel shareholder lawsuit (here).  Myriad share price is up 20% since mentioning the investigation.

Also in March, Natera Inc. settled a Department of Justice investigation into compliance with a $11M payment.  Press release here. Natera share price is up 26% since the press release.